Cargando…
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
Type 2 diabetes (T2D) is a very prevalent, multisystemic, chronic metabolic disorder closely related to atherosclerosis and cardiovascular diseases. It is characterised by mitochondrial dysfunction and the presence of oxidative stress. Metformin is one of the safest and most effective anti-hyperglyc...
Autores principales: | Apostolova, Nadezda, Iannantuoni, Francesca, Gruevska, Aleksandra, Muntane, Jordi, Rocha, Milagros, Victor, Victor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296337/ https://www.ncbi.nlm.nih.gov/pubmed/32535544 http://dx.doi.org/10.1016/j.redox.2020.101517 |
Ejemplares similares
-
Relationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes
por: De Marañon, Aranzazu M., et al.
Publicado: (2020) -
Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?
por: Canet, Francisco, et al.
Publicado: (2021) -
Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glycemic Control
por: de Marañón, Aranzazu Martinez, et al.
Publicado: (2020) -
Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes
por: Díaz-Pozo, Pedro, et al.
Publicado: (2022) -
Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes
por: Luna-Marco, Clara, et al.
Publicado: (2023)